Investigation of a single dose of Staccato alprazolam for inhalation on doxapram-induced panic attack in patients with panic disorder
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Alprazolam (Primary)
- Indications Panic disorder
- Focus Therapeutic Use
- Sponsors Alexza Pharmaceuticals
- 03 Jun 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 30 Apr 2008 Status changed to in progress as reported by Alexza Pharmaceuticals.
- 24 Apr 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History